A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
- Status
- TERMINATED
- Phase
- PHASE1
Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
- Status
- COMPLETED
- Phase
- N/A
Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study
- Status
- RECRUITING
- Phase
- N/A
Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy
- Status
- COMPLETED
- Phase
- N/A
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease
- Status
- RECRUITING
- Phase
- PHASE2
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response
- Status
- WITHDRAWN
- Phase
- PHASE2
Real World Study on the Efficacy and Safety of Anti-HER2 Therapy
- Status
- COMPLETED
- Phase
- N/A